Drug intelligence / Profile preview

zileuton extended release

Development stage
Approved
Lead developer
Chiesi
Modality
Small Molecules
Administration
Oral
01

Overview

Zileuton extended release is an oral small molecule drug used for the prevention and long-term management of asthma in adults and children aged 12 years and older. It is not indicated for the relief of acute asthma attacks. Zileuton's mechanism of action involves selective inhibition of 5-lipoxygenase, an enzyme critical to leukotriene synthesis from arachidonic acid. By blocking leukotriene formation (including LTB4, LTC4, LTD4, LTE4), it reduces airway inflammation, bronchoconstriction, edema, and mucus secretion associated with asthma. The drug is generally well-tolerated but can cause liver enzyme elevations; regular monitoring of liver function is recommended during therapy[1][6][9].

Brand names
Zyflo CR
Other names
zileuton ERzileuton extended-release tablets
02

Targets

ALOX12 (Arachidonate 12-lipoxygenase, 12S type)

Beyond the preview

Go deeper on zileuton extended release.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zileuton extended release.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call